Gene-gene Interaction in Asthma: IL4RA and IL13 in a Dutch Population with Asthma

Overview

Journal Am J Hum Genet

Publisher Cell Press

Specialty Genetics

Date 2001 Dec 13

PMID 11709756

Citations 105

Authors

Timothy D Howard

Gerard H Koppelman

Jianfeng Xu

Siqun L Zheng

Dirkje S Postma

Deborah A Meyers

Eugene R Bleecker

Affiliations

Soon will be listed here.

Abstract

Asthma is a common respiratory disease that is characterized by variable airways obstruction caused by acute and chronic bronchial inflammation; associated phenotypes include bronchial hyperresponsiveness (BHR), elevated total serum immunoglobulin E (IgE) levels, and skin tests positive to common allergens. Binding of interleukin-13 (IL13) or interleukin-4 (IL4) to the IL4 receptor (IL4R) induces the initial response for Th2 lymphocyte polarization. Both IL13 and IL4 are produced by Th2 cells and are capable of inducing isotype class-switching of B-cells to produce IgE after allergen exposure. These cytokines also share a common receptor component, IL4R alpha. We have investigated five IL4RA single-nucleotide polymorphisms in a population of Dutch families ascertained through a proband with asthma. By considering the probands and their spouses as an unrelated sample, we observed significant associations of atopy and asthma-related phenotypes with several IL4RA polymorphisms, including S478P and total serum IgE levels (P=.0007). A significant gene-gene interaction between S478P in IL4RA and the -1111 promoter variation in IL13, previously shown to be associated with BHR (P=.003), was detected. Individuals with the risk genotype for both genes were at almost five times greater risk for the development of asthma compared to individuals with both non-risk genotypes (P=.0004). These data suggest that variations in IL4RA contribute to elevated total serum IgE levels, and interaction between IL4RA and IL13 markedly increases an individual's susceptibility to asthma.

Citing Articles

SURFACTANT PROTEIN A: AN INNATE IMMUNE MODULATOR AND THERAPEUTIC IN ASTHMA.

Kraft M, Ledford J Trans Am Clin Climatol Assoc. 2024; 134:94-112.

PMID: 39135597 PMC: 11316857.

Diagnostic and therapeutic value of EVs in lungs diseases and inflammation.

Afzal A, Khawar M, Habiba U, Afzal H, Hamid S, Rafiq M Mol Biol Rep. 2023; 51(1):26.

PMID: 38127201 DOI: 10.1007/s11033-023-09045-5.

Rademikibart (CBP-201), a next-generation monoclonal antibody targeting human IL-4Rα: Two phase I randomized trials, in healthy individuals and patients with atopic dermatitis.

Wang J, White J, Sansone K, Spelman L, Sinclair R, Yang X Clin Transl Sci. 2023; 16(12):2614-2627.

PMID: 37849431 PMC: 10719461. DOI: 10.1111/cts.13656.

IL-4 receptor alpha signaling alters oral food challenge and immunotherapy outcomes in mice.

Ganesan V, Sharma A, Tomar S, Schuler 4th C, Hogan S J Allergy Clin Immunol. 2022; 151(1):182-191.e6.

PMID: 35934083 PMC: 11157665. DOI: 10.1016/j.jaci.2022.07.011.

Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13.

Pelaia C, Pelaia G, Crimi C, Maglio A, Armentaro G, Calabrese C Vaccines (Basel). 2022; 10(6).

PMID: 35746582 PMC: 9229960. DOI: 10.3390/vaccines10060974.

References

Mitsuyasu H, Izuhara K, Mao X, Gao P, Arinobu Y, Enomoto T . Ile50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma. Nat Genet. 1998; 19(2):119-20. DOI: 10.1038/472. View

Deichmann K, Heinzmann A, Forster J, Dischinger S, Mehl C, Brueggenolte E . Linkage and allelic association of atopy and markers flanking the IL4-receptor gene. Clin Exp Allergy. 1998; 28(2):151-5. DOI: 10.1046/j.1365-2222.1998.00159.x. View

Grunig G, Warnock M, Wakil A, Venkayya R, Brombacher F, Rennick D . Requirement for IL-13 independently of IL-4 in experimental asthma. Science. 1998; 282(5397):2261-3. PMC: 3897229. DOI: 10.1126/science.282.5397.2261. View

Howard T, Bleecker E, Stine O . Fluorescent allele-specific PCR (FAS-PCR) improves the reliability of single nucleotide polymorphism screening. Biotechniques. 1999; 26(3):380-1. DOI: 10.2144/99263bm01. View

Kruse S, Japha T, Tedner M, Sparholt S, Forster J, Kuehr J . The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction. Immunology. 1999; 96(3):365-71. PMC: 2326760. DOI: 10.1046/j.1365-2567.1999.00705.x. View

Drazen J, Yandava C, Dube L, Szczerback N, Hippensteel R, Pillari A . Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment. Nat Genet. 1999; 22(2):168-70. DOI: 10.1038/9680. View

Borish L, Nelson H, Lanz M, Claussen L, Whitmore J, Agosti J . Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial. Am J Respir Crit Care Med. 1999; 160(6):1816-23. DOI: 10.1164/ajrccm.160.6.9808146. View

Kruse S, Forster J, Kuehr J, Deichmann K . Characterization of the membrane-bound and a soluble form of human IL-4 receptor alpha produced by alternative splicing. Int Immunol. 1999; 11(12):1965-70. DOI: 10.1093/intimm/11.12.1965. View

Henderson Jr W, Chi E, Maliszewski C . Soluble IL-4 receptor inhibits airway inflammation following allergen challenge in a mouse model of asthma. J Immunol. 2000; 164(2):1086-95. DOI: 10.4049/jimmunol.164.2.1086. View

10.

Ober C, Leavitt S, Tsalenko A, Howard T, Hoki D, Daniel R . Variation in the interleukin 4-receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populations. Am J Hum Genet. 2000; 66(2):517-26. PMC: 1288105. DOI: 10.1086/302781. View

11.

Heinzmann A, Mao X, Akaiwa M, Kreomer R, Gao P, Ohshima K . Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet. 2000; 9(4):549-59. DOI: 10.1093/hmg/9.4.549. View

12.

Graves P, Kabesch M, Halonen M, Holberg C, Baldini M, Fritzsch C . A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J Allergy Clin Immunol. 2000; 105(3):506-13. DOI: 10.1067/mai.2000.104940. View

13.

Liu X, Nickel R, Beyer K, Wahn U, Ehrlich E, Freidhoff L . An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90). J Allergy Clin Immunol. 2000; 106(1 Pt 1):167-70. DOI: 10.1067/mai.2000.107935. View

14.

Drysdale C, McGraw D, Stack C, Stephens J, Judson R, Nandabalan K . Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A. 2000; 97(19):10483-8. PMC: 27050. DOI: 10.1073/pnas.97.19.10483. View

15.

Xu J, Postma D, Howard T, Koppelman G, Zheng S, Stine O . Major genes regulating total serum immunoglobulin E levels in families with asthma. Am J Hum Genet. 2000; 67(5):1163-73. PMC: 1288559. DOI: 10.1086/321190. View

16.

van der Pouw Kraan T, van Veen A, Boeije L, van Tuyl S, de Groot E, Stapel S . An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun. 2001; 1(1):61-5. DOI: 10.1038/sj.gene.6363630. View

17.

Hackstein H, Hecker M, Kruse S, Bohnert A, Ober C, Deichmann K . A novel polymorphism in the 5' promoter region of the human interleukin-4 receptor alpha-chain gene is associated with decreased soluble interleukin-4 receptor protein levels. Immunogenetics. 2001; 53(4):264-9. DOI: 10.1007/s002510100324. View

18.

Howard T, Whittaker P, Zaiman A, Koppelman G, Xu J, Hanley M . Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population. Am J Respir Cell Mol Biol. 2001; 25(3):377-84. DOI: 10.1165/ajrcmb.25.3.4483. View

19.

Burrows B, Martinez F, Halonen M, BARBEE R, Cline M . Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med. 1989; 320(5):271-7. DOI: 10.1056/NEJM198902023200502. View

20.

Sears M, Burrows B, Flannery E, Herbison G, Hewitt C, Holdaway M . Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N Engl J Med. 1991; 325(15):1067-71. DOI: 10.1056/NEJM199110103251504. View